Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
12.11
-0.03 (-0.25%)
At close: Sep 26, 2025, 4:00 PM EDT
12.12
+0.01 (0.08%)
After-hours: Sep 26, 2025, 5:21 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $148.41 million as of September 26, 2025. Its market cap has decreased by -76.62% in one year.
Market Cap
148.41M
Enterprise Value
34.27M
1-Year Change
-76.62%
Ranking
Category
Stock Price
$12.11
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $148.41M, an increase of 95.79%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 148.40M | 3.27% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |